Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01237353 · ClinicalTrials.gov registry record · NA
Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01237353 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 6 participants.
The verdict
NCT01237353, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
In this study the investigators will test a nutritional supplement called betaine hydrochloride to see if it can temporarily increase the stomach acid in healthy volunteers who have decreased stomach acid because they take a medicine called rabeprazole.
Interventions
- DRUG Rabeprazole
- DIETARY_SUPPLEMENT betaine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01237353
The ClinicalTrials.gov registry entry for NCT01237353 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Rabeprazole is the first listed.
NCT01237353 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01237353 about?
NCT01237353 is a clinical study titled "Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers". In this study the investigators will test a nutritional supplement called betaine hydrochloride to see if it can temporarily increase the stomach acid in healthy volunteers who have decreased stomach acid because they take a medicine called rabeprazole.
What is the current status of trial NCT01237353?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2011-03. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01237353?
The interventions under investigation include: Rabeprazole (DRUG), betaine hydrochloride (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01237353?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.